Geode Capital Management, LLC Ensysce Biosciences, Inc. Transaction History

Geode Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.05 - $153.6 $158 - $487,680	3,175 Added 2.49%	130,523 $28,000
Q2 2022 Aug 12, 2022	BUY	$100.8 - $345.6 $1.72 Million - $5.91 Million	17,102 Added 15.51%	127,348 $110,000
Q1 2022 May 13, 2022	BUY	$230.4 - $1140.0 $2.15 Million - $10.6 Million	9,325 Added 9.24%	110,246 $125,000
Q4 2021 Feb 11, 2022	BUY	$300.0 - $1228.8 $13.8 Million - $56.5 Million	45,991 Added 83.73%	100,921 $474,000
Q3 2021 Nov 12, 2021	BUY	$696.0 - $3477.6 $38.2 Million - $191 Million	54,930 New	54,930 $166,000

100

Ticker ENSC
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,918,900
Market Cap $1.25M
Description
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.